Literature DB >> 12529675

CD38 expression by hematopoietic stem cells of newborn and juvenile mice.

Y Higuchi1, H Zeng, M Ogawa.   

Abstract

While investigators in a number of laboratories have documented that the hematopoietic stem cells (HSCs) of fetal and adult mice are CD38+, no information is available about CD38 expression by HSCs of newborn and juvenile mice. We used a murine transplantation model to examine HSC CD38 expression. First, we observed that all HSCs from newborn bone marrow are CD38-. Next, it was determined that the majority of HSCs in the bone marrow of 5-week-old mice are CD38-, with a minority being CD38+. These observations indicated that the CD38+ subpopulation of HSC appears before the age of 5 weeks and expands during adolescence. However, the majority of HSCs of 5-week-old mice became CD38+ following injection of 5-fluorouracil, indicating that activation of juvenile stem cells enhances CD38 expression. These observations may have implications for CD38 expression by HSCs from human umbilical cord blood and bone marrow of young children in steady state and under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529675     DOI: 10.1038/sj.leu.2402785

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Authors:  Héctor Romero-Ramírez; Monserrat Teresa Morales-Guadarrama; Rosana Pelayo; Rubén López-Santiago; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Development of the fetal bone marrow niche and regulation of HSC quiescence and homing ability by emerging osteolineage cells.

Authors:  Süleyman Coşkun; Hsu Chao; Hema Vasavada; Kartoosh Heydari; Naomi Gonzales; Xin Zhou; Benoit de Crombrugghe; Karen K Hirschi
Journal:  Cell Rep       Date:  2014-10-09       Impact factor: 9.423

3.  Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers.

Authors:  Andre Larochelle; Michael Savona; Michael Wiggins; Stephanie Anderson; Brian Ichwan; Keyvan Keyvanfar; Sean J Morrison; Cynthia E Dunbar
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

Review 4.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

Review 5.  Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies.

Authors:  Hao-Tian Wu; Xiang-Yu Zhao
Journal:  Int J Biol Sci       Date:  2022-02-21       Impact factor: 6.580

Review 6.  MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma.

Authors:  FengXia Gao; SiRong He; AiShun Jin
Journal:  Genes Dis       Date:  2020-08-31

Review 7.  NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias.

Authors:  Renato Zambello; Gregorio Barilà; Sabrina Manni; Francesco Piazza; Gianpietro Semenzato
Journal:  Cells       Date:  2020-03-21       Impact factor: 6.600

Review 8.  Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions.

Authors:  Ashley Brauning; Michael Rae; Gina Zhu; Elena Fulton; Tesfahun Dessale Admasu; Alexandra Stolzing; Amit Sharma
Journal:  Cells       Date:  2022-03-17       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.